Cardiome Pharma Corp. (CRME) Stock Overview
USA - NASDAQ:CRME -
CRME Key Statistics, Chart & Performance
The current stock price of CRME is 2.33 null. In the past month the price decreased by -1.69%. In the past year, price decreased by -44.52%.
CRME Latest News, Press Relases and Analysis
.jpg)
About CRME
Company Profile
Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), and a pre-clinical program directed at improving cardiovascular function.
Company Info
Cardiome Pharma Corp.
1441 Creekside Drive 6th Floor
Vancouver A1 V6J 4S7
CEO: William L. Hunter
Phone: 604-677-6905
Cardiome Pharma Corp. / CRME FAQ
What is the stock price of Cardiome Pharma Corp. today?
The current stock price of CRME is 2.33 null. The price decreased by -2.1% in the last trading session.
What is the ticker symbol for Cardiome Pharma Corp. stock?
The exchange symbol of Cardiome Pharma Corp. is CRME and it is listed on the Nasdaq exchange.
On which exchange is CRME stock listed?
CRME stock is listed on the Nasdaq exchange.
What is Cardiome Pharma Corp. worth?
Cardiome Pharma Corp. (CRME) has a market capitalization of 81.25M null. This makes CRME a Micro Cap stock.
What are the support and resistance levels for Cardiome Pharma Corp. (CRME) stock?
Cardiome Pharma Corp. (CRME) has a support level at 2.32 and a resistance level at 2.35. Check the full technical report for a detailed analysis of CRME support and resistance levels.
Should I buy Cardiome Pharma Corp. (CRME) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CRME, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CRME, evaluating the profitability, health, valuation and growth aspects
- Cardiome Pharma Corp. (CRME) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Cardiome Pharma Corp. (CRME) Sales and EPS estimates to see what analysts future expectations are.
- Cardiome Pharma Corp. (CRME) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Cardiome Pharma Corp. (CRME) Insider and Institutional Ownership to learn about the owners and their transactions.
- Cardiome Pharma Corp. (CRME) Stock Chart to make your own analysis
- Cardiome Pharma Corp. (CRME) Latest news and press-releases to stay up to date.
Does Cardiome Pharma Corp. (CRME) stock pay dividends?
CRME does not pay a dividend.
What is the Price/Earnings (PE) ratio of Cardiome Pharma Corp. (CRME)?
Cardiome Pharma Corp. (CRME) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.9).
CRME Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to CRME. When comparing the yearly performance of all stocks, CRME turns out to be only a medium performer in the overall market: it outperformed 65.17% of all stocks.
CRME Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CRME. CRME has a bad profitability rating. Also its financial health evaluation is rather negative.
CRME Financial Highlights
Over the last trailing twelve months CRME reported a non-GAAP Earnings per Share(EPS) of -0.9. The EPS decreased by -13.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -125.98% | ||
| ROA | -54.06% | ||
| ROE | -351.31% | ||
| Debt/Equity | 4.31 |